News About: R&D
R&D investment found 4% level of net sales.
Domestic drug makers revealed their hot enthusiasm in developing new drugs amid expectation of the first birth of domestic new drug this year. Despite a difficult management environment under the IMF economic crisis t...
Patent dispute on Interferon anticancer drug ended.
A 8 year patent dispute on Interferon between Cheil Jedang and Roche, a Swiss multinational pharmaceutical corporation, has been ended recently.
The 2nd division of the Supreme Court (Chief Chancellor: Cho Moo-jae)...
New Drug R&D Union to build up technology mart.
So called Pharma-Tech Plaza, a technological cooperation market, seems to be established this year, where respective specialists in the new drug research and development and their projects would be gathered together f...
Hot competition in commercialization of the first new drug in Korea.
Since the second half of 1980s the research oriented pharmaceutical companies have made quite an investment for an R&D of new drug discovery, and now is the time for these companies to visualize their fruit for the fi...
1999 perspective in drug industry: R&D of new drugs
After the adoption of product patent system in 1987, the local drug industry has exerted its best efforts for developing new drugs.
Now, after a long dark tunnel, a small spot light seems to shine. SKI2053R (Sunfla...
New drug R&D no hindered by IMF crisis report meeting
Korea Union of New Drug Research and Development (Chairman: Lim Sung-ki) (KUNRD) plans to held a report meeting of the G7 research project at the international conference hall of Korea Institute of Science and ...
Amicable M&A possibility exposed to multinational corporation
Korea government eliminated restrictive provisions in stock markets, allowing foreigners to purchase up to 55% shares of a domestic firm, which provides many ossibilities for domestic pharmaceutical companies ...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
March
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
23 | 24 | 25 | 26 | 27 | 28 | 1 |
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 | 31 | 1 | 2 | 3 | 4 | 5 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
